Related Experiment Video
Updated: Jan 18, 2026

Genome-wide Surveillance of Transcription Errors in Eukaryotic Organisms
Published on: September 13, 2018
Heritable transcriptional defects from aberrations of nuclear architecture
Stamatis Papathanasiou1,2,3, Nikos A Mynhier4,5, Shiwei Liu5,6
1Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. s.papathanasiou@imb-mainz.de.
Abstract:
Transcriptional heterogeneity due to plasticity of the epigenetic state of chromatin contributes to tumour evolution, metastasis and drug resistance1-3. However, the mechanisms that cause this epigenetic variation are incompletely understood. Here we identify micronuclei and chromosome bridges, aberrations in the nucleus common in cancer4,5, as sources of heritable transcriptional suppression. Using a combination of approaches, including long-term live-cell imaging and same-cell single-cell RNA sequencing (Look-Seq2), we identified reductions in gene expression in chromosomes from micronuclei. With heterogeneous penetrance, these changes in gene expression can be heritable even after the chromosome from the micronucleus has been re-incorporated into a normal daughter cell nucleus. Concomitantly, micronuclear chromosomes acquire aberrant epigenetic chromatin marks. These defects may persist as variably reduced chromatin accessibility and reduced gene expression after clonal expansion from single cells. Persistent transcriptional repression is strongly associated with, and may be explained by, markedly long-lived DNA damage. Epigenetic alterations in transcription may therefore be inherently coupled to chromosomal instability and aberrations in nuclear architecture.
Insights
Cancer cells exhibit transcriptional heterogeneity, driven by epigenetic changes. This study reveals that micronuclei and chromosome bridges cause heritable gene silencing, contributing to tumour evolution and drug resistance.
Area of Science:
- Genetics
- Epigenetics
- Cancer Biology
Background:
- Transcriptional heterogeneity in cancer arises from epigenetic plasticity, impacting tumor evolution, metastasis, and drug resistance.
- The precise mechanisms driving this epigenetic variation remain largely unknown.
Purpose of the Study:
- To identify the sources of heritable transcriptional suppression in cancer cells.
- To elucidate the role of nuclear aberrations, specifically micronuclei and chromosome bridges, in epigenetic variation and gene expression.
Main Methods:
- Utilized long-term live-cell imaging to observe nuclear dynamics.
- Employed same-cell single-cell RNA sequencing (Look-Seq2) to analyze gene expression changes within individual cells.
- Investigated epigenetic marks and DNA damage associated with nuclear aberrations.
Main Results:
- Identified micronuclei as sources of heritable transcriptional suppression, with reduced gene expression in chromosomes within micronuclei.
- Demonstrated that gene expression changes can be inherited even after micronuclear chromosomes re-enter the main nucleus.
- Observed acquisition of aberrant epigenetic marks and long-lived DNA damage on micronuclear chromosomes, leading to persistent transcriptional repression and reduced chromatin accessibility.
Conclusions:
- Micronuclei and chromosome bridges are significant sources of heritable transcriptional suppression in cancer.
- Epigenetic alterations in transcription are intrinsically linked to chromosomal instability and nuclear architecture defects.
- These findings offer insights into tumour evolution, metastasis, and drug resistance mechanisms driven by epigenetic plasticity.
Related Concept Videos
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Inheritance of Chromatin Structures
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Genome Copying Errors
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

